ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Lung Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Warszawa, Mazowieckie, POL:

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

activity in participants with advanced metastatic colorectal cancer, ovarian cancer, renal cancer or pancreatic c....

Enrolling
Metastatic Pancreatic Carcinoma
Advanced Pancreatic Carcinoma
Drug: OATD-02

Phase 1

Molecure

Warsaw, Mazowieckie, Poland and 2 other locations

Locations recently updated

of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...

Enrolling
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: l-leucovorin
Drug: Gemcitabine

Phase 2

AstraZeneca
AstraZeneca

Warszawa, Poland and 48 other locations

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age...

Enrolling
Breast Cancer
Biliary Cancer
Drug: Camizestrant
Drug: Paclitaxel

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Warszawa, Poland and 73 other locations

The purpose of this study is to provide continued supply of ruxolitinib alone, ruxolitinib plus background cancer therapy, or background cancer...

Active, not recruiting
Breast Cancer
Colorectal Cancer (CRC)
Drug: Regorafenib
Drug: Capecitabine

Phase 2

Incyte
Incyte

Warszawa, Poland and 8 other locations

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of escalating doses of RMC-6291 (KRAS G12C(ON) inhibitor...

Enrolling
Colorectal Cancer (CRC)
Non-Small Cell Lung Cancer (NSCLC)
Drug: RMC-6291

Phase 1

Revolution Medicines
Revolution Medicines

Warsaw, Poland and 63 other locations

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor...

Active, not recruiting
Breast Cancer
Papillary Thyroid Cancer
Drug: Entrectinib

Phase 2

Roche
Roche

Warszawa, Poland and 122 other locations

consist of Part 1 which includes 7 cohorts of: urothelial bladder cancer, biliary tract cancer, cervical cancer, endometri ...

Enrolling
Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer
Drug: Trastuzumab deruxtecan

Phase 2

AstraZeneca
AstraZeneca

Warszawa, Poland and 113 other locations

and nab-paclitaxel, for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery ...

Active, not recruiting
Pancreas Adenocarcinoma
Drug: Gemcitabine
Drug: nab paclitaxel

Phase 3

NovoCure
NovoCure

Warsaw, Poland and 197 other locations

AFM24-102 is a Phase 1/2a open-label, non-randomized, multicenter, dose escalation, and expansion study evaluating AFM24 in combination with atezoliz...

Enrolling
Advanced Solid Tumor
Drug: AFM24
Drug: Atezolizumab 840 MG in 14 ML Injection

Phase 1, Phase 2

Affimed

Warsaw, Poland and 15 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems